Log in to save to my catalogue

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosim...

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosim...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5963670

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

About this item

Full title

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

Publisher

United States: Mary Ann Liebert, Inc

Journal title

Cancer biotherapy & radiopharmaceuticals, 2018-05, Vol.33 (4), p.155-165

Language

English

Formats

Publication information

Publisher

United States: Mary Ann Liebert, Inc

More information

Scope and Contents

Contents

This work describes the development and validation of a patient-specific Monte Carlo internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for Internal Dosimetry). RAPID utilizes serial PET/CT or SPECT/CT images to calculate voxelized three-dimensional (3D) internal dose distributions with the Monte Carlo code Geant4. RA...

Alternative Titles

Full title

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5963670

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5963670

Other Identifiers

ISSN

1084-9785

E-ISSN

1557-8852

DOI

10.1089/cbr.2018.2451

How to access this item